Hint mode is switched on Switch off
For swift navigation between sections

Biora Therapeutics
LEI 5493005XOS7E58D57T10

PDF download

Choose all Reset all
Download Cancel
Organization name
Biora Therapeutics Inc (formerly Progenity Inc)
Country name
USA
Country of registration
USA
Industry
Medical Services
Public debt
19 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Biora Therapeutics Inc (formerly Progenity Inc) provides health care testing services. The Company offers complex molecular diagnostic solutions. Progenity serves customers in the United States.

Awards

News

27/12/2024 Biora Therapeutics: Entry Into A Material Definitive Agreement, Bankruptcy Or Receivership, Triggering Events That Accelerate Or Increase A Direct Financial Obligation Under An Offbalance Sheet Arrangement, Regulation Fd Disclosure, Financial Statements And Exhibits
10/12/2024 Biora Therapeutics: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of
13/11/2024 Biora Therapeutics: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
28/10/2024 Biora Therapeutics: Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Financial Statements And Exhibits
09/10/2024 Biora Therapeutics: Material Modification To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2024
I q eng
II q eng
III q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
II q eng
III q eng
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    5493005XOS7E58D57T10
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001580063
  • EIN
    27-3950390
Registration is required to get access.